Periostin: A novel prognostic and therapeutic target for genitourinary cancer?

Clinical Genitourinary Cancer

Volumn 12, Issue 5, 2014, Pages 301-311

  Nuzzo, Pier Vitale ^a,b   Buzzatti, Giulia ^a,b   Ricci, Francesco ^a   Rubagotti, Alessandra ^a,b   Argellati, Francesca ^a   Zinoli, Linda ^a,b   Boccardo, Francesco ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Biomarker; Extracellular matrix protein; Genitourinary tumors; Isoform; POSTN protein

Indexed keywords

COLLAGEN TYPE 1; COMPLEMENTARY DNA; FIBRONECTIN; FOCAL ADHESION KINASE; GELATINASE A; GELATINASE B; NERVE CELL ADHESION MOLECULE; NOTCH1 RECEPTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROCOLLAGEN C PROTEINASE; PROTEIN; PROTEIN KINASE B; STROMELYSIN; TENASCIN; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR ACTIVATED KINASE BINDING PROTEIN 1; UNCLASSIFIED DRUG; UVOMORULIN; VASCULOTROPIN RECEPTOR 2; CELL ADHESION MOLECULE; ISOPROTEIN; POSTN PROTEIN, HUMAN; SCLEROPROTEIN; TUMOR MARKER;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ALTERNATIVE RNA SPLICING; AMINO TERMINAL SEQUENCE; ANGIOGENESIS; BLADDER CANCER; CANCER CELL LINE; CANCER PROGNOSIS; CANCER SURVIVAL; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL ADHESION; CELL DIFFERENTIATION; CELL INVASION; CELL MIGRATION; CELL SURVIVAL; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; EXON; GENETIC VARIABILITY; GLEASON SCORE; HUMAN; INTRACELLULAR SIGNALING; KIDNEY CANCER; LASER CAPTURE MICRODISSECTION; NONHUMAN; OPEN READING FRAME; OVERALL SURVIVAL; PENIS CANCER; PROSTATE CANCER; PROTEIN PROTEIN INTERACTION; RECURRENCE FREE SURVIVAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; UPREGULATION; UROGENITAL TRACT CANCER; WESTERN BLOTTING; BIOSYNTHESIS; EXTRACELLULAR MATRIX; GENETICS; METABOLISM; PATHOLOGY; PROGNOSIS; PROTEIN SECONDARY STRUCTURE; UROGENITAL TRACT TUMOR;

CELL ADHESION; CELL ADHESION MOLECULES; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; HUMANS; PROGNOSIS; PROTEIN ISOFORMS; PROTEIN STRUCTURE, SECONDARY; TUMOR MARKERS, BIOLOGICAL; UROGENITAL NEOPLASMS;

EID: 84922668611     PISSN: 15587673     EISSN: 19380682     Source Type: Journal    
DOI: 10.1016/j.clgc.2014.02.005     Document Type: Review

References (74)

1. Takeshita S, Kikuno R, Tezuka K, et al. Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem J 1993; 294:271-8
2. Horiuchi K, Amizuka N, Takeshita S, et al. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res 1999; 14:1239-49
3. Takayama G, Arima K, Kanaji T, et al. Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J Allergy Clin Immunol 2006; 118:98-104
4. Norris RA, Borg TK, Butcher JT, et al. Neonatal and adult cardiovascular pathophysiological remodeling and repair: developmental role of periostin. Ann NY Acad Sci 2008; 1123:30-40
5. Kuhn B, del Monte F, Hajjar RJ, et al. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat Med 2007; 13:962
6. Lie-Venema H, Eralp I, Markwald RR, et al. Periostin expression by epicardiumderived cells is involved in the development of the atrioventricular valves and fibrous heart skeleton. Differentiation 2008; 76:809-19
7. Wang D, Oparil S, Feng JA, et al. Effects of pressure overload on extracellular matrix expression in the heart of the atrial natriuretic peptide-null mouse. Hypertension 2003; 42:88-95
8. Goetsch SC, Hawke TJ, Gallardo TD, et al. Transcriptional profiling and regulation of the extracellular matrix during muscle regeneration. Physiol Genomics 2003; 14:261-71
9. Nakazawa T, Nakajima A, Seki N, et al. Gene expression of periostin in the early stage of fracture healing detected by cDNA microarray analysis. J Orthop Res 2004; 22:520-5
10. Li P, Oparil S, Feng W, et al. Hypoxia-responsive growth factors upregulate periostin and osteopontin expression via distinct pathways in rat pulmonary arterial smooth muscle cells. J Appl Physiol (1985) 2004; 97:1550-8
11. Sehra S, Yao W, Nguyen ET, et al. Periostin regulates goblet cell metaplasia in a model of allergic airway inflammation. J Immunol 2011; 186:4959-66
12. Tai IT, Dai M, Chen LB. Periostin induction in tumor cell line explants and inhibition of in vitro cell growth by anti-periostin antibodies. Carcinogenesis 2005; 26:908-15
13. Ruan K, Bao S, Ouyang G. The multifaceted role of periostin in tumorigenesis. Cell Mol Life Sci 2009; 66:2219-30
14. Yan W, Shao R. Transduction of a mesenchyme-specific gene periostin into 293T cells induces cell invasive activity through epithelial-mesenchymal transformation. J Biol Chem 2006; 281:700-8
15. Kim CJ, Sakamoto K, Tambe Y, et al. Opposite regulation of epithelial-tomesenchymal transition and cell invasiveness by periostin between prostate and bladder cancer cells. Int J Oncol 2011; 38:1759-66
16. Litvin J, Selim A, Montgomery M, et al. Expression and function of periostinisoforms in bone. J Biol Chem 2004; 92:1044-61
17. Kiefer F, Arnold K, Künzli M, Bordoli L, Schwede T. The SWISS-MODEL Repository and associated resources. Nucleic Acids Res 2009; 37:D387-92
18. Kopp J, Schwede T. The SWISS-MODEL Repository of annotated threedimensional protein structure homology models. Nucleic Acids Res 2004; 32: D230-4
19. Doliana R, Bot S, Bonaldo P, et al. EMI, a novel cysteine-rich domain of EMILINs and other extracellular proteins, interacts with the gC1q domains and participates in multimerization. FEBS Lett 2000; 484:164-8
20. Callebaut I, Mignotte V, Souchet M, et al. EMI domains are widespread and reveal the probable orthologs of the Caenorhabditis elegans CED-1 protein. Biochem Biophys Res Commun 2003; 300:619-23
21. Hoersch S, Andrade-Navarro MA. Periostin shows increased evolutionary plasticity in its alternatively spliced region. BMC Evol Biol 2010; 10:30
22. Coutu DL, Wu JH, Monette A, et al. Periostin, a member of a novel family of vitamin K-dependent proteins, is expressed by mesenchymal stromal cells. J Biol Chem 2008; 283:17991-8001
23. Norris RA, Moreno-Rodriguez RA, Sugi Y, et al. Periostin regulates atrioventricular valve maturation. Dev Biol 2008; 316:200-13
24. Kii I, Nishiyama T, Li M, et al. Incorporation of tenascin-C into the extracellular matrix by periostin underlies an extracellular meshwork architecture. Biol Chem 2010; 285:2028-39
25. Tanabe H, Takayama I, Nishiyama T, et al. Periostin associates with Notch1 precursor to maintain Notch1 expression under a stress condition in mouse cells. PLoS One 2010; 5:e12234
26. Maruhashi T, Kii I, Saito M, Kudo A. Interaction between periostin and BMP-1 promotes proteolytic activation of lysyl oxidase. J Biol Chem 2010; 285: 13294-303
27. Sugiura T, Takamatsu H, Kudo A, et al. Expression and characterization of murine osteoblast-specific factor 2 (OSF-2) in a baculovirus expression system. Protein Expr Purif 1995; 6:305-11
28. Gillan L, Matei D, Fishman DA, Gerbin CS, Karlan BY, Chang DD. Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. Cancer Res 2002; 62: 5358-64
29. Kim CJ, Isono T, Tambe Y, et al. Role of alternative splicing of periostin in human bladder carcinogenesis. Int J Oncol 2008; 32:161-9
30. Bai Y, Nakamura M, Zhou G, et al. Novel isoforms of periostin expressed in the human thyroid. Jpn Clin Med 2010; 1:13-20
31. Litvin J, Zhu S, Norris R, et al. Periostin family of proteins: therapeutic targets for heart disease. Anat Rec A Discov Mol Cell Evol Biol 2005; 287:1205-12
32. Song G, Ouyang G, Bao S. The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 2005; 9:59-71
33. Bao S, Ouyang G, Bai X, et al. Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. Cancer Cell 2004; 5:329-39
34. Baril P, Gangeswaran R, Mahon PC, et al. Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta4 integrin and the PI3k pathway. Oncogene 2007; 26:2082-94
35. Erkan M, Kleeff J, Gorbachevski A, et al. Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity. Gastroenterology 2007; 132:1447-64
36. Shao R, Bao S, Bai X, et al. Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression. Mol Cell Biol 2004; 24:3992-4003
37. Takanami I, Abiko T, Koizumi S. Expression of periostin in patients with nonesmall-cell lung cancer: correlation with angiogenesis and lymphangiogenesis. Int J Biol Markers 2008; 23:182-6
38. Morra L, Moch H. Periostin expression and epithelial-mesenchymal transition in cancer: a review and an update. Virchows Arch 2011; 459:465-75
39. Soltermann A, Tischler V, Arbogast S, et al. Prognostic significance of epithelialmesenchymal and mesenchymal-epithelial transition protein expression in none small-cell lung cancer. Clin Cancer Res 2008; 14:7430-7
40. Kudo Y, Ogawa I, Kitajima S, et al. Periostin promotes invasion and anchorageindependent growth in the metastatic process of head and neck cancer. Cancer Res 2006; 66:6928-35
41. Siriwardena BS, Kudo Y, Ogawa I, et al. Periostin is frequently overexpressed and enhances invasion and angiogenesis in oral cancer. Br J Cancer 2006; 95:1396-403
42. Kudo Y, Iizuka S, Yoshida M, et al. Periostin directly and indirectly promotes tumor lymphangiogenesis of head and neck cancer. PLoS One 2012; 7:e44488
43. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992; 69:11-25
44. Varner JA, Cheresh DA. Integrins and cancer. Curr Opin Cell Biol 1996; 8:724-30
45. Mizejewski GJ. Role of integrins in cancer: survey of expression patterns. Proc Soc Exp Biol Med 1999; 222:124-38
46. Brooks PC, Montgomery AM, Rosenfeld M, et al. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994; 79:1157-64
47. Nicholson KM, Anderson NG. The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 2002; 14:381-95
48. Stupack DG, Cheresh DA. Get a ligand, get a life: integrins, signaling and cell survival. J Cell Sci 2002; 115:3729-38
49. Cheng GZ, Park S, Shu S, et al. Advances of AKT pathway in human oncogenesis and as a target for anti-cancer drug discovery. Curr Cancer Drug Targets 2008; 8: 2-6
50. Ledford H. Cancer theory faces doubts. Nature 2011; 472:273
51. Malanchi I, Santamaria-Martínez A, Susanto E, et al. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 2011; 481:85-9
52. Tilman G, Mattiussi M, Brasseur F, van Baren N, Decottignies A. Human periostin gene expression in normal tissues, tumors and melanoma: evidences for periostin production by both stromal and melanoma cells. Mol Cancer 2007; 6:80
53. Sasaki H, Yu CY, Dai M, et al. Elevated serum periostin levels in patients with bone metastases from breast but not lung cancer. Breast Cancer Res Treat 2003; 77: 245-52
54. Sasaki H, Dai M, Auclair D, et al. Serum level of the periostin, a homologue of an insect cell adhesion molecule, as a prognostic marker in nonesmall-cell lung carcinomas. Cancer 2001; 92:843-8
55. Furusato B, Tsunoda T, Shaheduzzaman S, et al. Osteoblast-specific factor 2 expression in prostate cancer-associated stroma: identification through microarray technology. Urology 2010; 75:768-72
56. Tian Y, Bova GS, Zhang H. Quantitative glycoproteomic analysis of optimal cutting temperature-embedded frozen tissues identifying glycoproteins associated with aggressive prostate cancer. Anal Chem 2011; 83:7013-9
57. Sun C, Zhao X, Xu K, et al. Periostin: a promising target of therapeutical intervention for prostate cancer. J Transl Med 2011; 9:99
58. Chen J, Xi J, Tian Y, et al. Identification, prioritization, and evaluation of glycoproteins for aggressive prostate cancer using quantitative glycoproteomics and antibody-based assays on tissue specimens. Proteomics 2013; 15:2268-77
59. Tsunoda T, Furusato B, Takashima Y, et al. The increased expression of periostin during early stages of prostate cancer and advanced stages of cancer stroma. Prostate 2009; 69:1398-403
60. Tischler V, Fritzsche FR, Wild PJ, et al. Periostin is up-regulated in high grade and high stage prostate cancer. BMC Cancer 2010; 10:273
61. Nuzzo PV, Rubagotti A, Zinoli L, et al. Prognostic value of stromal and epithelial periostin expression in human prostate cancer: correlation with clinical pathological features and the risk of biochemical relapse or death. BMC Cancer 2012; 12:625
62. Planche A, Bacac M, Provero P, et al. Identification of prognostic molecular features in the reactive stroma of human breast and prostate cancer. PLoS One 2011; 6:e18640
63. Sun C, Song C, Ma Z, et al. Periostin identified as a potential biomarker of prostate cancer by iTRAQ-proteomics analysis of prostate biopsy. Proteome Sci 2011; 9:22
64. Argellati F, Nuzzo PV, Ricci F, et al. Dihydrotestosterone and bicalutamide do not affect periostin expression in androgen-dependent LNCaP prostate cancer cell lines. Anticancer Res 2013; 33:815-20
65. Kim CJ, Yoshioka N, Tambe Y, et al. Periostin is down-regulated in high grade human bladder cancers and suppresses in vitro cell invasiveness and in vivo metastasis of cancer cells. Int J Cancer 2005; 117:51-8
66. Isono T, Kim CJ, Ando Y, Sakurai H, Okada Y, Inoue H. Suppression of cell invasiveness by periostin via TAB1/TAK1. Int J Oncol 2009; 35:425-32
67. Shibuya H, Yamaguchi K, Shirakabe K, et al. TAB1: an activator of the TAK1 MAPKKK in TGF-beta signal transduction. Science 1996; 272:1179-82
68. Sakurai H, Miyoshi H, Toriumi W, et al. Functional interactions of transforming growth factor beta-activated kinase 1 with IkappaB kinase to stimulate NF-kappaB activation. J Biol Chem 1999; 274:10641-8
69. Castronovo V, Waltregny D, Kischel P, et al. A chemical proteomics approach for the identification of accessible antigens expressed in human kidney cancer. Mol Cell Proteomics 2006; 5:2083-91
70. Morra L, Rechsteiner M, Casagrande S, et al. A relevance of periostin splice variants in renal cell carcinoma. Am J Pathol 2011; 179:1513-21
71. Dahinden C, Ingold B, Wild P, et al. Mining tissue microarray data to uncover combinations of biomarker expression patterns that improve intermediate staging and grading of clear cell renal cell cancer. Clin Cancer Res 2010; 16: 88-98
72. Gunia S, Jain A, Koch S, et al. Periostin expression correlates with pT-stage, grading and tumour size, and independently predicts cancer-specific survival in surgically treated penile squamous cell carcinomas. J Clin Pathol 2013; 66: 297-301
73. Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin 2012; 62: 10-29
74. Orecchia P, Conte R, Balza E, et al. Identification of a novel cell binding site of periostin involved in tumour growth. Eur J Cancer 2011; 47:2221-9.